Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This review discusses an algorithm using patient history, clinical examination, and tests to help diagnose hair loss in women, but it reports no new clinical results.

This study found that the most common cause of diffuse hair loss in Jordanian females was telogen effluvium, often triggered by nutritional deficiencies and various forms of stress.

This study found that trichoscopic measurements of hair density and diameter are useful for assessing the severity of female pattern hair loss and its progression.

In this study, zinc deficiency, iron depletion, and thyroid abnormalities were commonly observed in female pattern hair loss patients, suggesting the benefit of testing for these conditions.

This study developed and validated an objective dermoscopic severity score for evaluating female pattern hair loss, which may serve as a supplementary outcome measure in therapeutic trials.

This article discusses the potential use of human hair follicular stem cells combined with platelet-rich plasma for androgenetic alopecia, focusing on the regenerative processes involved, but reports no new clinical results.

This article discusses female pattern hair loss and concludes that the utility of lab markers for screening associated conditions remains unclear; no new clinical results are presented.

Flutamide, an oral anti-androgen therapy, is effective in treating female pattern hair loss, even without systemic androgen excess.

This article discusses female pattern hair loss and explores potential causes beyond androgenic factors, reporting no new research findings.

This study found that HLA-B*57 and HLA-Cw*06 were associated with increased risk of psoriasis vulgaris, while KIR2DL2 was more prevalent in controls, suggesting a protective effect.

This paper discusses how studying hair follicles in the balding scalp could reveal fundamental biological processes, without reporting new experimental findings.

No link found between new male baldness genes and female hair loss.

This study found that nuclear androgen receptor levels varied among females with androgen-dependent dermatoses, being highest in hirsutism, which may suggest superior androgen stimulability compared to acne and androgenetic alopecia.

This study identified a moderately high prevalence of PCOS and significant associations with factors like hyperprolactinemia and menstrual irregularities in the sample, emphasizing the importance of awareness and early diagnosis to potentially reduce PCOS burden.

This article provides citations without reporting new findings on androgen conjugate levels in alopecia.

This case study reported two instances of female androgenetic alopecia with male pattern reversed after surgical removal of an ovarian tumor.

Androgenetic alopecia causes distressing hair loss in aging men and women.

Hair loss in women often doesn't follow a pattern, isn't linked to age, may be genetic, and can be related to thyroid issues or other health factors.

In this study, researchers examined women with androgenic alopecia in the Indian subcontinent and found varying patterns of hair loss, with inconclusive hormonal profiles but potentially useful hair pull tests and trichograms.

In this study, the researchers noted that approximately 15% of hair transplant procedures are performed on women, with candidacy being determined by specific anatomical conditions and hair loss types, such as medium-stage androgenetic alopecia or a high frontal hairline.

This overview discusses the causes and evaluation of hyperandrogenism in Australian women and reviews current management strategies, without presenting new clinical results.

This case report describes a 14-year-old girl with signs of virilization, including increased facial and body hair, deepened voice, and elevated serum testosterone and androstenedione levels.

This study found distinct proteomic differences between male and female androgenetic alopecia, highlighting sex-specific molecular pathways and potential biomarkers for pattern hair loss.

In this study, FGF5-knockout Dorper sheep generated using CRISPR/Cas9 showed increased fine-wool and active hair-follicle density, suggesting potential therapeutic applications for androgen alopecia.

This study found that women had better knowledge and interest in androgenetic alopecia than men, especially about its definition and normal hair loss rates, but both sexes struggled with understanding its etiology and symptoms.

This study found that lower serum ferritin levels are associated with an increased risk of non-scarring alopecia in non-menopausal women, indicating that assessing iron stores is important for managing this condition.

This study found that parents of women with PCOS have a higher prevalence of insulin resistance and Type II diabetes than parents of healthy women.

In this clinical study, low-level laser therapy using the HANDI-DOME LASER device increased hair counts by 51% compared to controls, indicating its potential as a safe and effective treatment for androgenetic alopecia in women aged 18 to 60.

This study found that in Korea, nonbald individuals perceive balding men as older and less attractive, with women more likely than nonbald men to view them as less attractive.

This study in north Sudan found that 25% of women have traction alopecia, with the condition linked to factors like family history of pattern baldness and the use of hair color or chemicals, while increasing age was associated with a lower risk.